First results of a national deployment of a fully automated central-line-associated bloodstream infection (CLABSI) surveillance system, Switzerland, 2022 to 2023.
Gaud Catho(University of Geneva), Niccolò Buetti(University of Geneva), Peter W. Schreiber(University Hospital of Zurich), Lauro Damonti(University Hospital of Bern), Bruno Grandbastien(University of Lausanne), Philipp Jent(University of Bern), Estelle Moulin, Loïc Fortchantre(University of Geneva), Claudine Reiber, Jason Toko, Jan Adam Roth, Alexandra U Scherrer, Sarah Tschudin-Sutter, Walter Zingg, Stephan Harbarth, Lorenzo Ciullini, Elia Lo Priore, Carlo Balmelli
Cited by 0
Related Papers
Personal protective equipment and intensive care unit healthcare worker safety in the COVID-19 era (PPE-SAFE): An international survey
|Journal of Critical Care|2020|350
Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study
|Intensive Care Medicine|2023|257
Cefepime neurotoxicity: thresholds and risk factors. A retrospective cohort study
|Clinical Microbiology and Infection|2019|143
Diagnostic accuracy of a SARS-CoV-2 rapid antigen test in real-life clinical settings
|International Journal of Infectious Diseases|2021|133
Guidelines for Diagnosis and Management of Infective Endocarditis in Adults
|JAMA Network Open|2023|108